Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Review Status	Status Date	View
CXSS2300016	舒格利单抗注射液	Sugemalimab	Injection	Biological Products(2.2)	New Drug Application	2023-04-05				view
CXSS2300007	舒格利单抗注射液	Sugemalimab	Injection	Biological Products(2.2)	New Drug Application	2023-02-28				view
CYSB2300028	舒格利单抗注射液	Sugemalimab	Injection	Biological Products	Supplementary Application	2023-02-04				view
CYSB2300013	舒格利单抗注射液	Sugemalimab	Injection	Biological Products	Supplementary Application	2023-01-11				view
CYSB2200232	舒格利单抗注射液	Sugemalimab	Injection	Biological Products(1)	Supplementary Application	2022-09-22				view
CXSS2200077	舒格利单抗注射液	Sugemalimab	Injection	Biological Products(2.2)	New Drug Application	2022-09-08				view
CYSB2200223	舒格利单抗注射液	Sugemalimab	Injection	Biological Products(1)	Supplementary Application	2022-09-07				view
CXSS2101026	舒格利单抗注射液	Sugemalimab	Injection	Biological Products(1)	New Drug Application	2021-09-06				view
CXSS2000056	舒格利单抗注射液	Sugemalimab	Injection	Biological Products(1)	New Drug Application	2020-11-13	基石药业（苏州）有限公司,无锡药明生物技术股份有限公司	Approval Completed-Pending Certificated	2021-12-20	view